Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolein P M Hensgens

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|December 8, 2011
Time interval of increased risk for Clostridium difficile infection after exposure to antibioticsMarjolein P M Hensgens, Abraham Goorhuis, Olaf M Dekkers, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Osteonecrosis as late complication in HIV-infected patients]Marjolein P M Hensgens, T Tania Mudrikova, Jan T M van der Meer
Vaccines|January 8, 2025
Vaccination Coverage for Medically Indicated Vaccines in a Convenience Sample of Severely Immunocompromised Patients with COVID-19: An Observational Cohort StudyElsemieke Te Linde, Marjolein P M Hensgens, Albert M Vollaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort studyMarjolein P M Hensgens, Abraham Goorhuis, Olaf M Dekkers, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 23, 2025
[Personalized management of Staphylococcus aureus bacteraemia: guidelines for optimal diagnostics and treatment]Ilse J E Kouijzer, Jaap Ten Oever, Marjolein P M Hensgens, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 29, 2022
[Current inpatient treatment options for COVID-19: an update]Marjolein P M Hensgens, Emilie Gieling, Dylan de Lange, et al.
Infection Control and Hospital Epidemiology|June 9, 2017
External Validation of Three Prediction Tools for Patients at Risk of a Complicated Course of Clostridium difficile Infection: Disappointing in an Outbreak SettingYvette H van Beurden, Marjolein P M Hensgens, Olaf M Dekkers, et al.
Idcases|October 29, 2025
An 80-year-old man with a rare disease manifestation of disseminated cryptococcosisWouter L Smit, Laura M Vos, Gerdie M de Jong, et al.
Microbiology (Reading, England)|August 30, 2011
Genetic markers for Clostridium difficile lineages linked to hypervirulenceCornelis W Knetsch, Marjolein P M Hensgens, Céline Harmanus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosisMartijn P Bauer, Marjolein P M Hensgens, Mark A Miller, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|December 8, 2011
Time interval of increased risk for Clostridium difficile infection after exposure to antibioticsMarjolein P M Hensgens, Abraham Goorhuis, Olaf M Dekkers, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Osteonecrosis as late complication in HIV-infected patients]Marjolein P M Hensgens, T Tania Mudrikova, Jan T M van der Meer
Vaccines|January 8, 2025
Vaccination Coverage for Medically Indicated Vaccines in a Convenience Sample of Severely Immunocompromised Patients with COVID-19: An Observational Cohort StudyElsemieke Te Linde, Marjolein P M Hensgens, Albert M Vollaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort studyMarjolein P M Hensgens, Abraham Goorhuis, Olaf M Dekkers, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 23, 2025
[Personalized management of Staphylococcus aureus bacteraemia: guidelines for optimal diagnostics and treatment]Ilse J E Kouijzer, Jaap Ten Oever, Marjolein P M Hensgens, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 29, 2022
[Current inpatient treatment options for COVID-19: an update]Marjolein P M Hensgens, Emilie Gieling, Dylan de Lange, et al.
Infection Control and Hospital Epidemiology|June 9, 2017
External Validation of Three Prediction Tools for Patients at Risk of a Complicated Course of Clostridium difficile Infection: Disappointing in an Outbreak SettingYvette H van Beurden, Marjolein P M Hensgens, Olaf M Dekkers, et al.
Idcases|October 29, 2025
An 80-year-old man with a rare disease manifestation of disseminated cryptococcosisWouter L Smit, Laura M Vos, Gerdie M de Jong, et al.
Microbiology (Reading, England)|August 30, 2011
Genetic markers for Clostridium difficile lineages linked to hypervirulenceCornelis W Knetsch, Marjolein P M Hensgens, Céline Harmanus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosisMartijn P Bauer, Marjolein P M Hensgens, Mark A Miller, et al.
Pageof 2